Table 2 Univariate analysis to identify the candidate risks of PEGF

Cause of ESRD

 Unknown

70 (71.4)

91 (53.2)

2.19 (1.29–3.74)

0.004

 Known

28 (28.6)

80 (46.8)

Recipient baseline creatinine (mg/dL)

 >8.5

54 (56.8)

64 (39.0)

2.06 (1.23–3.44)

0.007

 ≤8.5

41 (43.2)

100 (60.9)

Pretransplant PRA (%)

 >50

24 (25.0)

15 (8.9)

3.4 (1.68–6.87)

<0.001

 ≤50

72 (75.0)

153 (91.1)

Donor type

 Deceased

87 (88.8)

39 (22.8)

26.77 (13.33–56.65)

<0.001

 Living

11 (11.2)

132 (77.2)

Donor age (year)

 >55

21 (21.9)

13 (7.8)

3.29 (1.57–6.94)

0.002

 ≤55

75 (78.1)

153 (92.2)

Donor gender

 Female

22 (22.4)

88 (51.5)

0.27 (0.15–0.47)

<0.001

 Male

76 (77.6)

83 (48.5)

HLA-A+B+DR mismatch

 >2

75 (76.5)

144 (84.2)

0.61 (0.33–1.14)

0.143

 ≤2

23 (13.5)

27 (15.8)

WIT (min)

 >45

42 (43.8)

54 (32.5)

1.59 (0.95–2.68)

0.084

 ≤45

54 (56.3)

111 (66.8)

CIT (h)

 >12

84 (85.7)

33 (19.3)

25.09 (13.44–53.09)

<0.001

 ≤12

14 (14.3)

138 (80.7)

EBL (mL)

 >500

28 (28.6)

23 (13.5)

2.57 (1.38–4.79)

0.003

 ≤500

70 (71.4)

148 (86.5)

Perioperative Hb decrement (g/dL)

 >1.35

53 (54.1)

42 (24.6)

3.62 (2.13–6.14)

<0.001

 ≤1.35

45 (45.9)

129 (75.4)

Percentage of Hb decrement (%)

 >12.50

51 (52.0)

42 (24.6)

3.33 (1.97–5.65)

<0.001

 ≤12.50

47 (48.0)

129 (75.4)